NCT01209273

Brief Summary

The objective of this study is to compare Quality of Life (QoL) between Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2010

Longer than P75 for all trials

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 27, 2010

Completed
4 days until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

September 15, 2015

Status Verified

September 1, 2015

Enrollment Period

2.3 years

First QC Date

September 24, 2010

Last Update Submit

September 11, 2015

Conditions

Keywords

Quality of LifeAutomated Peritoneal DialysisContinuous Ambulatory Peritoneal DialysisEnd Stage Renal Disease

Outcome Measures

Primary Outcomes (1)

  • Change in Quality of Life

    change in quality of life and patient satisfaction scores from start to dialysis to 1yr between APD group and CAPD group.

    1yr

Study Arms (2)

APD group

which can be 3 to 5 exchanges daily, and up to 20 liters daily( including up to two daytime exchanges)

CAPD group

which can be 1 to 4 exchanges daily and up to 16 liters daily(including up to two daytime exchanges)

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Incident PD patients in Korea

You may qualify if:

  • Male or female subjects at least 20 and older at that time of obtaining informed consent
  • Subjects performing CAPD or APD
  • Subject with a total Kt/V≥ 1.7 at baseline

You may not qualify if:

  • Subjects who have undergone abdominal surgery within the last 30 days except for PD catheter insertion
  • Subjects who is planned for renal transplantation or hemodialysis within 1 year following the date of informed consent
  • Subjects who have received antibiotics for the treatment of peritonitis, exit-site or tunnel infection within the last 30 days
  • Subjects who have active liver disease such as cirrhosis of the liver, active hepatitis or other active liver disease as evidenced by biopsy, laboratory (unstable liver enzymes over the last 90 days) or clinical examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Inje University Haeundae Paik Hospital

Busan, 614-735, South Korea

Location

Samsung Changwon Hospital

Changwon, 630-520, South Korea

Location

Chungbuk National University Hospital

Cheongju-si, 361-790, South Korea

Location

Kyungpook National University Hospital

Daegu, 700-721, South Korea

Location

Daegu Fatima Hospital

Daegu, 701-600, South Korea

Location

Eulji University Hospital

Daejeon, 302-799, South Korea

Location

Chosun University Hospital

Gwangju, 501-717, South Korea

Location

Jeju National University Hospital

Jeju City, South Korea

Location

Korea University Anam Hospital

Seoul, 136-705, South Korea

Location

Eulji General Hospital

Seoul, 139-711, South Korea

Location

St. Carolo Hospital

Suncheon, 501-757, South Korea

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood 24hr urine PD dialysate

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yong-Lim Kim, M.D., Ph.D.

    Division of Nephrology, Department of Internal Medicine, Kyungpook National University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 24, 2010

First Posted

September 27, 2010

Study Start

October 1, 2010

Primary Completion

February 1, 2013

Study Completion

September 1, 2015

Last Updated

September 15, 2015

Record last verified: 2015-09

Locations